Category: NuvasiveSyndicate content

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

August 12, 2014 by Brad Perriello

HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Judge denies NuVasive in NeuroVision spat, cancels trademark

August 11, 2014 by Brad Perriello

A federal judge denies NuVasive's bid to overturn a $30 million trademark infringement loss and cancels its trademark on the NeuroVision name.

Judge denies NuVasive in NeuroVision spat, cancels trademark

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive soars on Q2 sales, earnings beats

July 30, 2014 by Brad Perriello

NuVasive shares surge more than 10% as the medical device company raises its outlook for the rest of the year after posting 2nd-quarter sales and earnings numbers that beat estimates.

NuVasive soars on Q2 sales, earnings beats

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive launches spine surgery monitoring platform

June 23, 2014 by Brad Perriello

NuVasive launches the latest version of its NVM5 monitoring platform for spinal surgeries.

NuVasive launches spine surgery monitoring platform

NuVasive Inc. (NSDQ:NUVA) said today that it's launching the next generation of its NVM5 patient monitoring platform for spine surgeries.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DOJ probes St. Jude | Medtech legal news for the week of May 12, 2014

May 12, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Justice Dept. probes St. Jude for potential False Claims, kickbacks violations; More secret human studies uncovered in Myxo ring inquiry; Medtech manufacturer fleeced Stryker, says former exec; FDA morcellator warning spurs lawsuit against J&J; NuVasive claims win in patent spat with Cadwell Labs

Justice Dept. probes St. Jude for potential False Claims, kickbacks violations

May 6, 2014 by Arezu Sarvestani

NuVasive claims win in patent spat with Cadwell Labs

May 6, 2014 by Brad Perriello

NuVasive says it's settled a patent infringement lawsuit over neuromonitoring technology with Cadwell Laboratories, which agreed to exit the lateral spine surgery market and might be on the hook for royalties.

NuVasive settles patent spat with Cadwell Labs

NuVasive Inc. (NSDQ:NUVA) said today that Cadwell Laboratories agreed to settle a patent spat over neuromonitoring technology by exiting the lateral spine market and potentially paying 5% royalties to NuVasive for future products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp